N-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney disease

Nutrients

Volumn 8, Issue 3, 2016, Pages

  Barden, Anne ^a   O’Callaghan, Nathan ^b   Burke, Valerie ^a   Mas, Emile ^a   Beilin, Lawrence J ^a   Fenech, Michael ^b   Irish, Ashley B ^c   Watts, Gerald F ^a   Puddey, Ian B ^a   Huang, Rae Chi ^d   Mori, Trevor A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CSIRO   (Australia)

^c FIONA STANLEY HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Coenzyme Q10; N 3 fatty acids; Neutrophils; Oxidative stress; Telomere length

Indexed keywords

UBIDECARENONE; ANTIOXIDANT; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; DRUG COMBINATION; ICOSAPENTAENOIC ACID; ISOPROSTANE DERIVATIVE; OMEGA 3 ACID ETHYL ESTER; UBIQUINONE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; NEUTROPHIL COUNT; OXIDATIVE STRESS; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE HOMEOSTASIS; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECTS; GENETICS; METABOLISM; MONONUCLEAR CELL; MULTICENTER STUDY; NEUTROPHIL; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC; TELOMERE; TIME FACTOR; TREATMENT OUTCOME; WESTERN AUSTRALIA;

ADULT; AGED; ANTIOXIDANTS; BIOMARKERS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; F2-ISOPROSTANES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC; TELOMERE; TELOMERE HOMEOSTASIS; TIME FACTORS; TREATMENT OUTCOME; UBIQUINONE; WESTERN AUSTRALIA;

EID: 84962558072     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8030175     Document Type: Article

References (47)

1. Aviv, A. Telomeres and human somatic fitness. J. Gerontol. Ser. A-Biol. Sci. Med. Sci. 2006, 61, 871-873. [CrossRef]
2. Lipcsey, M.; Soederberg, E.; Basu, S.; Larsson, A.; Sjoelin, J.; Astroem, M.; Eriksson, M.B. F-2-isoprostane, inflammation, cardiac function and oxygenation in the endotoxaemic pig. Prostag. Leukotr. Ess. 2008, 78, 209-217. [CrossRef] [PubMed]
3. Bansal, N.; Whooley, M.A.; Regan, M.; McCulloch, C.E.; Ix, J.H.; Epel, E.; Blackburn, E.; Lin, J.; Hsu, C.-Y. Association between kidney function and telomere length: The heart and soul study. Am. J. Nephrol. 2012, 36, 405-411. [CrossRef] [PubMed]
4. Boxall, M.C.; Goodship, T.H.J.; Brown, A.L.; Ward, M.C.; von Zglinicki, T. Telomere shortening and haemodialysis. Blood Purif. 2006, 24, 185-189. [CrossRef] [PubMed]
5. Tsirpanlis, G.; Chatzipanagiotou, S.; Boufidou, F.; Kordinas, V.; Alevyzaki, F.; Zoga, M.; Kyritsis, I.; Stamatelou, K.; Triantafyllis, G.; Nicolaou, C. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. Am. J. Nephrol. 2006, 26, 91-96. [CrossRef] [PubMed]
6. Carrero, J.J.; Stenvinkel, P.; Fellstrom, B.; Qureshi, A.R.; Lamb, K.; Heimburger, O.; Barany, P.; Radhakrishnan, K.; Lindholm, B.; Soveri, I. Telomere attrition is associated with inflammation, low fetuin-a levels and high mortality in prevalent haemodialysis patients. J. Intern. Med. 2008, 263, 302-312. [CrossRef] [PubMed]
7. Aviv, A.; Chen, W.; Gardner, J.P.; Kimura, M.; Brimacombe, M.; Cao, X.; Srinivasan, S.R.; Berenson, G.S. Leukocyte telomere dynamics: Longitudinal findings among young adults in the Bogalusa heart study. Am. J. Epidemiol. 2009, 169, 323-329. [CrossRef] [PubMed]
8. Sanders, J.L.; Fitzpatrick, A.L.; Boudreau, R.M.; Arnold, A.M.; Aviv, A.; Kimura, M.; Fried, L.F.; Harris, T.B.; Newman, A.B. Leukocyte telomere length is associated with noninvasively measured age-related disease: The cardiovascular health study. J. Gerontol. Ser. A-Biol. Sci. Med. Sci. 2012, 67, 409-416. [CrossRef] [PubMed]
9. Shammas, M.A. Telomeres, lifestyle, cancer, and aging. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 28-34. [CrossRef] [PubMed]
10. Pavlaki, K.I.; Kastrinaki, M.-C.; Klontzas, M.; Velegraki, M.; Mavroudi, I.; Papadaki, H.A. Abnormal t elomereshortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia. Haematol. Hematol. J. 2012, 97, 743-750. [CrossRef] [PubMed]
11. Brummendorf, T.H.; Maciejewski, J.P.; Mak, J.; Young, N.S.; Lansdorp, P.M. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood 2001, 97, 895-900. [CrossRef] [PubMed]
12. Compte, N.; Bailly, B.; De Breucker, S.; Goriely, S.; Pepersack, T. Study of the association of total and differential white blood cell counts with geriatric conditions, cardio-vascular diseases, seric il-6 levels and telomere length. Exp. Gerontol. 2015, 61, 105-112. [CrossRef] [PubMed]
13. Sela, S.; Shurtz-Swirski, R.; Cohen-Mazor, M.; Mazor, R.; Chezar, J.; Shapiro, G.; Hassan, K.; Shkolnik, G.; Geron, R.; Kristal, B. Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J. Am. Soc. Nephrol. 2005, 16, 2431-2438. [CrossRef] [PubMed]
14. Mori, T.A.; Puddey, I.B.; Burke, V.; Croft, K.D.; Dunstan, D.W.; Rivera, J.H.; Beilin, L.J. Effect of ! 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox Rep. 2000, 5, 45-46. [CrossRef] [PubMed]
15. Mori, T.A.; Dunstan, D.W.; Burke, V.; Croft, K.D.; Rivera, J.H.; Beilin, L.J.; Puddey, I.B. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism 1999, 48, 1402-1408. [CrossRef]
16. Mas, E.; Woodman, R.J.; Burke, V.; Puddey, I.B.; Beilin, L.J.; Durand, T.; Mori, T.A. The omega-3 fatty acids EPA and DHA decrease plasma F2-isoprostanes: Results from two placebo-controlled interventions. Free Radic. Res. 2010, 44, 983-990. [CrossRef] [PubMed]
17. Singh, U.; Devaraj, S.; Jialal, I. Coenzyme Q10 supplementation and heart failure. Nutr. Rev. 2007, 65, 286-293. [CrossRef] [PubMed]
18. Alleva, R.; Tomasetti, M.; Battino, M.; Curatola, G.; Littarru, G.P.; Folkers, K. The roles of coenzyme Q10 and vitamin-E on the peroxidation of human low-density-lipoprotein subfractions. Proc. Natl. Acad. Sci. USA 1995, 92, 9388-9391. [CrossRef] [PubMed]
19. Tomasetti, M.; Littarru, G.P.; Stocker, R.; Alleva, R. Coenzyme Q10 enrichment decreases oxidative DNA damage in human lymphocytes. Free Radic. Biol. Med. 1999, 27, 1027-1032. [CrossRef]
20. Cachofeiro, V.; Goicochea, M.; Garcia de Vinuesa, S.; Oubina, P.; Lahera, V.; Luno, J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. 2008, 74, S4-S9. [CrossRef] [PubMed]
21. Richard, M.J.; Sirajeddine, M.K.; Cordonnier, D.; Tricot, F.; Foulon, T.; Mouneimne, A.; Maurizi, J. Relationship of omega-3 fatty acid supplementation to plasma lipid peroxidation in predialysis patients with hypertriglyceridaemia. Eur. J. Med. 1993, 2, 15-18. [PubMed]
22. Mori, T.A.; Burke, V.; Puddey, I.B.; Irish, A.B.; Cowpland, C.A.; Beilin, L.J.; Dogra, G.K.; Watts, G.F. The effects of omega 3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: A randomized controlled trial. J. Hypertens. 2009, 27, 1863-1872. [CrossRef] [PubMed]
23. Lu, T.; Pan, Y.; Kao, S.Y.; Li, C.; Kohane, I.; Chan, J.; Yankner, B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429, 883-891. [CrossRef] [PubMed]
24. Cawthon, R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002, 30, e47. [CrossRef] [PubMed]
25. Tsai, I.J.; Croft, K.D.; Mori, T.A.; Falck, J.R.; Beilin, L.J.; Puddey, I.B.; Barden, A.E. 20-HETE and F2-isoprostanes in the metabolic syndrome: The effect of weight reduction. Free Radic. Biol. Med. 2009, 46, 263-270. [CrossRef] [PubMed]
26. Woodman, R.J.; Watts, G.F.; Puddey, I.B.; Burke, V.; Mori, T.A.; Hodgson, J.M.; Beilin, L.J. Leukocyte count and vascular function in type 2 diabetic subjects with treated hypertension. Atherosclerosis 2002, 163, 175-181. [CrossRef]
27. Weng, N.P. Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J. Leukoc. Biol. 2001, 70, 861-867. [PubMed]
28. Denburg, J.A.; Hatfield, H.M.; Cyr, M.M.; Hayes, L.; Holt, P.G.; Sehmi, R.; Dunstan, J.A.; Prescott, S.L. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr. Res. 2005, 57, 276-281. [CrossRef] [PubMed]
29. Summers, C.; Rankin, S.M.; Condliffe, A.M.; Singh, N.; Peters, A.M.; Chilvers, E.R. Neutrophil kinetics in health and disease. Trends Immunol. 2010, 31, 318-324. [CrossRef] [PubMed]
30. Wang, Y.X.; Yao, S.L.; Shu, H.Q.; Liu, H.; Yuan, S.Y.; Chen, X.D.; Li, R.D.; Wu, X.Y.; Guo, L.; Wang, Y. Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway. J. Surg. Res. 2014, 188, 213-221.
31. Mas, E.; Barden, A.; Burke, V.; Beilin, L.J.; Watts, G.F.; Huang, R.C.; Puddey, I.B.; Irish, A.B.; Mori, T.A. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Clin. Nutr. 2015. in press. [CrossRef] [PubMed]
32. Barden, A.E.; Burke, V.; Mas, E.; Beilin, L.J.; Puddey, I.B.; Watts, G.F.; Irish, A.B.; Mori, T.A. n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease. J. Hypertens. 2015, 33, 1947-1953. [CrossRef] [PubMed]
33. Farzaneh-Far, R.; Lin, J.; Epel, E.S.; Harris, W.S.; Blackburn, E.H.; Whooley, M.A. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA J. Am. Med. Assoc. 2010, 303, 250-257. [CrossRef] [PubMed]
34. O’Callaghan, N.; Parletta, N.; Milte, C.M.; Benassi-Evans, B.; Fenech, M.; Howe, P.R.C. Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomized controlled pilot study. Nutrition 2014, 30, 489-491. [CrossRef] [PubMed]
35. Kiecolt-Glaser, J.K.; Epel, E.S.; Belury, M.A.; Andridge, R.; Lin, J.; Glaser, R.; Malarkey, W.B.; Hwang, B.S.; Blackburn, E. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav. Immun. 2013, 28, 16-24. [CrossRef] [PubMed]
36. Cattan, V.; Mercier, N.; Gardner, J.P.; Regnault, V.; Labat, C.; Maki-Jouppila, J.; Nzietchueng, R.; Benetos, A.; Kimura, M.; Aviv, A. Chronic oxidative stress induces a tissue-specific reduction in telomere length in cast/ei mice. Free Radic. Biol. Med. 2008, 44, 1592-1598. [CrossRef] [PubMed]
37. Tarry-Adkins, J.L.; Ozanne, S.E.; Norden, A.; Cherif, H.; Hales, C.N. Lower antioxidant capacity and elevated p53 and p21 may be a link between gender disparity in renal telomere sh ortening, albuminuria, and longevity.Am. J. Physiol. Ren. Physiol. 2006, 290, F509-F516. [CrossRef] [PubMed]
38. Epel, E.S.; Blackburn, E.H.; Lin, J.; Dhabhar, F.S.; Adler, N.E.; Morrow, J.D.; Cawthon, R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA 2004, 101, 17312-17315. [CrossRef] [PubMed]
39. Demissie, S.; Levy, D.; Benjamin, E.J.; Cupples, L.A.; Gardner, J.P.; Herbert, A.; Kimura, M.; Larson, M.G.; Meigs, J.B.; Keaney, J.F.; et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the framingham heart study. Aging Cell 2006, 5, 325-330. [CrossRef] [PubMed]
40. Ziegler-Heitbrock, L. Monocyte subsets in man and other species. Cell. Immunol. 2014, 289, 135-139. [CrossRef] [PubMed]
41. Hellerstein, M.K. Measurement of T-cell kinetics: Recent methodologic advances. Immunol. Today 1999, 20, 438-441. [CrossRef]
42. Dlouha, D.; Maluskova, J.; Lesna, I.K.; Lanska, V.; Hubacek, J.A. Comparison of the relative telomere length measured in leukocytes and eleven different human tissues. Physiol. Res. 2014, 63, S343-S350. [PubMed]
43. Lin, J.; Epel, E.; Cheon, J.; Kroenke, C.; Sinclair, E.; Bigos, M.; Wolkowitz, O.; Mellon, S.; Blackburn, E. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. J. Immunol. Methods 2010, 352, 71-80. [CrossRef] [PubMed]
44. Krysiak, R.; Okopien, B. Lymphocyte-suppressing action of angiotensin-converting enzyme inhibitors in coronary artery disease patients with normal blood pressure. Pharmacol. Rep. 2011, 63, 1151-1161. [CrossRef]
45. Dincer, Y.; Sekercioglu, N.; Pekpak, M.; Gunes, K.N.; Akcay, T. Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease. Ren. Fail. 2008, 30, 1006-1011. [CrossRef] [PubMed]
46. Ramirez-Tortosa, M.C.; Granados, S.; Ramirez-Tortosa, C.L.; Ochoa, J.J.; Camacho, P.; Garcia-Valdes, L.; Battino, M.; Quiles, J.L. Oxidative stress status in liver mitochondria and lymphocyte DNA damage of atherosclerotic rabbits supplemented with water soluble coenzyme Q10. Biofactors 2008, 32, 263-273. [CrossRef] [PubMed]
47. Niklowitz, P.; Sonnenschein, A.; Janetzky, B.; Andler, W.; Menke, T. Enrichment of coenzyme Q10 in pl asmaand blood cells: Defense against oxidative damage. Int. J. Biol. Sci. 2007, 3, 257-262. [CrossRef] [PubMed]